ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Evaluation of Residual Urine After Intermittent Catheterisation

This study has been completed.

Sponsored by: Coloplast A/S
Information provided by: Coloplast A/S
ClinicalTrials.gov Identifier: NCT00324233
  Purpose

Intermittent catheterization is a well-known method used for emptying the bladder. The objective of this study is to compare the residual urine after intermittent catheterisation with 2 different, hydrophilic coated, intermittent catheters. The study is a randomized, single blinded, crossover study including 24 healthy males.


Condition Intervention
Healthy
Device: Intermittent catheter

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Randomized, Single Blind, Active Control, Crossover Assignment, Safety/Efficacy Study
Official Title:   Evaluation of Residual Urine After Intermittent Catheterisation – Comparison of 2 Hydrophilic Coated, Intermittent Catheters

Further study details as provided by Coloplast A/S:

Primary Outcome Measures:
  • Residual urine measured by ultra sound

Secondary Outcome Measures:
  • Hematuria measured by urine multi-dipstick
  • Subjectively measured discomfort
  • Subjectively measured handling
  • Subjectively measured insertion of the catheter

Estimated Enrollment:   24
Study Start Date:   April 2006
Estimated Study Completion Date:   June 2006

  Eligibility
Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Male
  • 18 years and above
  • A negative urine dip-stick
  • Have signed informed written consent to participate

Exclusion Criteria:

  • The test participant has previous or current congenital deformity, diseases or operation in the lower urinary tract
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00324233

Locations
Denmark, København Ø
Rigshospitalet    
      Copenhagen, København Ø, Denmark, 2100

Sponsors and Collaborators
Coloplast A/S

Investigators
Principal Investigator:     Per Bagi, MD     Rigshospitalet, Denmark    
  More Information


Study ID Numbers:   DK052CC
First Received:   May 9, 2006
Last Updated:   May 25, 2007
ClinicalTrials.gov Identifier:   NCT00324233
Health Authority:   Denmark: The Danish National Committee on Biomedical Research Ethics

Keywords provided by Coloplast A/S:
Residual urine  
Hematuria  
Ultra sound  

Study placed in the following topic categories:
Hematuria
Healthy

ClinicalTrials.gov processed this record on October 03, 2008




Links to all studies - primarily for crawlers